Omega Healthcare Investors Inc. Files Definitive Proxy Statement

Ticker: OHI · Form: DEF 14A · Filed: Apr 23, 2024 · CIK: 888491

Omega Healthcare Investors Inc DEF 14A Filing Summary
FieldDetail
CompanyOmega Healthcare Investors Inc (OHI)
Form TypeDEF 14A
Filed DateApr 23, 2024
Risk Levellow
Pages15
Reading Time18 min
Sentimentneutral

Sentiment: neutral

Topics: DEF 14A, Proxy Statement, Omega Healthcare Investors, Executive Compensation, Corporate Governance

TL;DR

<b>Omega Healthcare Investors Inc. has filed its Definitive Proxy Statement for the period ending June 7, 2024.</b>

AI Summary

OMEGA HEALTHCARE INVESTORS INC (OHI) filed a Proxy Statement (DEF 14A) with the SEC on April 23, 2024. Omega Healthcare Investors Inc. filed a Definitive Proxy Statement (DEF 14A) on April 23, 2024. The filing covers the period ending June 7, 2024. The company's fiscal year ends on December 31. Omega Healthcare Investors Inc. is a Real Estate Investment Trust (SIC 6798). The filing includes details on equity awards and compensation for applicable years.

Why It Matters

For investors and stakeholders tracking OMEGA HEALTHCARE INVESTORS INC, this filing contains several important signals. This DEF 14A filing provides shareholders with crucial information regarding executive compensation, director elections, and other corporate governance matters, enabling informed voting decisions. As a Real Estate Investment Trust, OHI's proxy statement is important for understanding its financial structure, operational performance, and strategic direction as it relates to shareholder value.

Risk Assessment

Risk Level: low — OMEGA HEALTHCARE INVESTORS INC shows low risk based on this filing. The filing is a routine DEF 14A, indicating standard corporate disclosures rather than immediate material events.

Analyst Insight

Review the executive compensation details and any proposals to be voted on to understand potential impacts on shareholder value and corporate strategy.

Key Numbers

  • 2024-06-07 — Reporting Period End Date (Conformed period of report)
  • 2024-04-23 — Filing Date (Filed as of date)
  • 1231 — Fiscal Year End (Fiscal year end)
  • 6798 — SIC Code (Standard Industrial Classification)

Key Players & Entities

  • OMEGA HEALTHCARE INVESTORS INC (company) — Filer name
  • 0000888491 (company) — Central Index Key
  • MD (location) — State of incorporation and business address
  • 303 INTERNATIONAL CIRCLE, SUITE 200 (location) — Business and mailing address
  • HUNT VALLEY (location) — City for business and mailing address
  • 21030 (location) — ZIP code for business and mailing address
  • 410-427-1700 (phone) — Business phone number

FAQ

When did OMEGA HEALTHCARE INVESTORS INC file this DEF 14A?

OMEGA HEALTHCARE INVESTORS INC filed this Proxy Statement (DEF 14A) with the SEC on April 23, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by OMEGA HEALTHCARE INVESTORS INC (OHI).

Where can I read the original DEF 14A filing from OMEGA HEALTHCARE INVESTORS INC?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by OMEGA HEALTHCARE INVESTORS INC.

What are the key takeaways from OMEGA HEALTHCARE INVESTORS INC's DEF 14A?

OMEGA HEALTHCARE INVESTORS INC filed this DEF 14A on April 23, 2024. Key takeaways: Omega Healthcare Investors Inc. filed a Definitive Proxy Statement (DEF 14A) on April 23, 2024.. The filing covers the period ending June 7, 2024.. The company's fiscal year ends on December 31..

Is OMEGA HEALTHCARE INVESTORS INC a risky investment based on this filing?

Based on this DEF 14A, OMEGA HEALTHCARE INVESTORS INC presents a relatively low-risk profile. The filing is a routine DEF 14A, indicating standard corporate disclosures rather than immediate material events.

What should investors do after reading OMEGA HEALTHCARE INVESTORS INC's DEF 14A?

Review the executive compensation details and any proposals to be voted on to understand potential impacts on shareholder value and corporate strategy. The overall sentiment from this filing is neutral.

How does OMEGA HEALTHCARE INVESTORS INC compare to its industry peers?

Omega Healthcare Investors Inc. operates as a Real Estate Investment Trust (REIT) within the healthcare sector, focusing on skilled nursing and assisted living facilities.

Are there regulatory concerns for OMEGA HEALTHCARE INVESTORS INC?

As a publicly traded company, OHI is subject to SEC regulations and reporting requirements, including the filing of proxy statements for shareholder meetings.

Industry Context

Omega Healthcare Investors Inc. operates as a Real Estate Investment Trust (REIT) within the healthcare sector, focusing on skilled nursing and assisted living facilities.

Regulatory Implications

As a publicly traded company, OHI is subject to SEC regulations and reporting requirements, including the filing of proxy statements for shareholder meetings.

What Investors Should Do

  1. Review the proposals to be voted on at the shareholder meeting.
  2. Analyze executive compensation packages and any changes proposed.
  3. Assess director nominations and qualifications.

Year-Over-Year Comparison

This is a DEF 14A filing, which is a standard disclosure document for annual meetings and does not represent a change from previous filings in terms of document type.

Filing Stats: 4,437 words · 18 min read · ~15 pages · Grade level 12.7 · Accepted 2024-04-23 16:30:40

Filing Documents

Executive Compensation Tables and Related Information

Executive Compensation Tables and Related Information 52 Policy on Related Party Transactions 24 Summary Compensation Table 52 Code of Business Conduct and Ethics 24 Grants of Plan-Based Awards 53 Stock Ownership Guidelines 24 Outstanding Equity Awards at Fiscal Year End 55 Policy on Hedging and Pledging of Company Securities 25 Stock Awards Vested for 2023 56 Director Retirement Policy 25 Nonqualified Deferred Compensation 57 Director Over-Boarding Policy 26 Employment Agreements 58 Proxy Access and Universal Proxy 26 Potential Payments Upon Termination or Change in Control 58 Corporate Governance Materials 26 Chief Executive Officer Pay Ratio Disclosure 60 Proposal 2 - Proposal to Ratify the Selection of Ernst & Young LLP as our 27 Pay Versus Performance 60 Independent Auditor for the Fiscal Year 2024 Compensation of Directors 62 Recommendation of the Board 27 Compensation Committee Interlocks and Insider Participation 64 Vote Required for Approval 27 Stockholder Proposals and Nominations 64 Audit Committee and Independent Auditor Matters 28 Quorum and Voting 65 Audit Committee Report 28 Expenses of Solicitation 66 Independent Auditors 29 Householding 67 Fees 29 Other Matters 67 Determination of Auditor Independence 29 Our Commitment to The Environment Audit Committee's Pre-Approval Policies 29 Annual Meeting of Stockholders Proposal 3 - Advisory Vote on Executive Compensation 30 Recommendation of the Board 30 Table of Contents Proxy Summary This summary highlights information contained elsewhere in this Proxy Statement and does not contain all of the information you should consider. Please read the entire Proxy Statement carefully before voting. Annual Meeting Logistics WHEN June 7, 2024 at 10:00 am EDT WEBCAST virtualshareholdermeeting.com/OHI2024 RECORD DATE April 8, 2024 Voting Guide PROPOSAL 1 E

Executive Compensation Highlights (Page 42)

Executive Compensation Highlights (Page 42) Below we have included selected executive compensation highlights for the Company for fiscal year 2023. ceo target compensation mix avg. other neos target compensation mix 4 Table of Contents Summary of compensation program Base Salary (Cash) Fixed level of cash compensation to attract and retain key executives in a competitive marketplace Preserves an executive's commitment during downturns Determined based on evaluation of individual executives, compensation, internal pay equity and a comparison to the peer group Annual Incentive (Cash) Target cash incentive opportunity (set as a percentage of base salary) to encourage achievement of annual Company financial and operational goals Assists in attracting, retaining and motivating executives in the near term Majority (70% for 2023) of incentive opportunity based on objective performance measures, which includes Funds Available for Distribution ("FAD") per Share, Tenant Quality and Leverage A portion (30% for 2023) of the payout is also based on performance against individual-specific subjective goals Long-Term Incentive (EQUITY) RSUs and Profits Interest Units ( Time-based ) Focuses executives on achievement of long-term financial and strategic goals and Absolute TSR and TSR relative to an index of healthcare peer REITs ("Relative TSR"), thereby creating long-term stockholder value Assists in maintaining a stable, continuous management team in a competitive market Maintains stockholder management alignment Easy to understand and track performance Limits dilution to existing stockholders relative to utilizing stock options 40% of target annual long-term incentive awards in 2023 Provides upside incentive in up-market, with some down-market protection Three-year cliff vest (subject to certain exceptions) PRSUs and Profits Interest Units ( Performance-based ) 60% of target annual long-term incentive award in 2023, requi

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.